Altrafin AG’s Virgin Galactic SPCE Stock Holding History

Altrafin AG’s Portfolio SPCE Stock Details SPCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-700	Closed	-$138K	–	85
2022 Q1	$138K	Sell	700 -304	-30%	-$56.8K	0.05%	83
2021 Q4	$269K	Buy	+1,004	New	+$363K	0.1%	84

Other funds holding SPCE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Altrafin AG's SPCE Position: Q2 2022 in Review

Altrafin AG sold out of Virgin Galactic (SPCE) in Q2 2022, closing a stake of 700 shares — an estimated $138K sold.

Altrafin AG first reported a position in SPCE in Q4 2021 and held it in 2 quarters. The position peaked at $269K in Q4 2021. 266 funds tracked by Wall St. Rank hold SPCE as of Q2 2022.

Altrafin AG reported no remaining Virgin Galactic position as of Q2 2022 after selling out during the quarter.
Altrafin AG sold 700 Virgin Galactic shares in Q2 2022, an estimated $138K.
Altrafin AG first reported a position in Virgin Galactic in Q4 2021 and held it in 2 quarters.
Altrafin AG's Virgin Galactic position peaked at $269K in Q4 2021.
266 funds tracked by Wall St. Rank held Virgin Galactic as of Q2 2022.

Based on Altrafin AG's 13F filing for Q2 2022, filed 17 Feb 2026.